Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Silymarin-Albumin Nanoplex: Preparation and Its Potential Application As an Antioxidant in Nervous System in Vitro and in Vivo Publisher Pubmed



Sohrabi MJ1 ; Dehpour AR1 ; Attar F2 ; Hasan A3, 4 ; Mohammadsadeghi N5 ; Meratan AA5 ; Aziz FM6 ; Salihi A6, 7 ; Shekha MS6, 8 ; Akhtari K9 ; Shahpasand K10 ; Hojjati SMM11 ; Sharifi M12 ; Saboury AA13 Show All Authors
Authors
  1. Sohrabi MJ1
  2. Dehpour AR1
  3. Attar F2
  4. Hasan A3, 4
  5. Mohammadsadeghi N5
  6. Meratan AA5
  7. Aziz FM6
  8. Salihi A6, 7
  9. Shekha MS6, 8
  10. Akhtari K9
  11. Shahpasand K10
  12. Hojjati SMM11
  13. Sharifi M12
  14. Saboury AA13
  15. Rezayat SM1, 14
  16. Mousavi SE1
  17. Falahati M12
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Biology, Faculty of Food Industry & Agriculture, Standard Research Institute (SRI), Karaj, Iran
  3. 3. Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, Doha, 2713, Qatar
  4. 4. Biomedical Research Center, Qatar University, Doha, 2713, Qatar
  5. 5. Department of Biological Sciences, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran
  6. 6. Department of Biology, College of Science, Salahaddin University-Erbil, Kurdistan Region, Iraq
  7. 7. Department of Medical Analysis, Faculty of Science, Tishk International University, Erbil, Iraq
  8. 8. Department of Pathological Analysis, College of Science, Knowledge University, Erbil, 074016, Kurdistan Region, Iraq
  9. 9. Department of Physics, University of Kurdistan, P.O. Box 416, Sanandaj, Iran
  10. 10. Royan Institute for Stem Cell Biology and Technology (RI-SCBT), Tehran, Iran
  11. 11. Department of Neurology, Babol University of Medical Sciences, Babol, Iran
  12. 12. Department of Nanotechnology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  13. 13. Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
  14. 14. Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Pharmaceutics Published:2019


Abstract

In this study, we formulated silymarin-HSA nanoplex and assayed its ability to reduce LPS-induced toxicity in vitro and in vivo. Silymarin molecules were encapsulated into HSA nanoplex and the loading efficiency and characterization of fabricated nanoplex were performed by using HPLC, TEM, SEM, DLS, FTIR analysis, and theoretical studies. Afterwards, their protective effect against LPS (20 µg/ml) -induced toxicity in SH-SY5Y cells was investigated by MTT, ROS, and apoptosis assays. For in vivo experiments, rats were pre-treated with either silymarin or silymarin -HSA nanoplex (200 mg/kg) orally for 3 days and at third day received LPS by IP at a dose of 0.5 mg/kg, 150 min before scarification followed by SOD and CAT activity assay. The formulation of silymarin-HSA nanoplex showed a spherical shape with an average diameter between 50 nm and 150 nm, hydrodynamic radius of 188.3 nm, zeta potential of −26.6 mV, and a drug loading of 97.3%. In LPS-treated cells, pretreatments with silymarin-HSA noncomplex recovered the cell viability and decreased the ROS level and corresponding apoptosis more significantly than free silymarin. In rats, it was also depicted that, silymarin-HSA noncomplex can increase the SOD and CAT activity in brain tissue at LPS-triggered oxidative stress model more significantly than the free counterpart. Therefore, nanoformulation of silymarin improved its capability to reduce LPS-induced oxidative stress by restoring cell viability and elevation of SOD and CAT activity in vitro and in vivo, respectively. In conclusion, formulation of silymarin may hold a great promise in the development of antioxidant agents. © 2019 Elsevier B.V.